Polaris
is a California-based biotechnology company that develops and commercializes novel anti-cancer therapies for the treatment of cancer... Read morePolaris
is a California-based biotechnology company that develops and commercializes novel anti-cancer therapies for the treatment of cancer... Read more
CEO
Steve J.P. Hsu
News
Mar 13, 2026
Marketscreener
Polaris: Polaris Group Reports Earnings Results for the Full Year Ended December 31, 2025
Nov 12, 2025
Marketscreener
Polaris: Polaris Group Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
Dec 22, 2023
BioSpace
Polaris: Polaris Group Announced the Acquisition of Genovior Biotech, Initiating Dual-Engine Growth
Dec 04, 2023
MarketScreener
Polaris: Polaris Group Initiates Phase 3 Trial: First Patient Successfully Dosed with ADI-PEG 20/Placebo plus Gemcitabine and Docetaxel for Difficult-to-Treat Leiomyosarcoma (LMS)
Nov 17, 2023
StreetInsider
Press Release: Polaris : Polaris Group Initiates Rolling Submission of Biologic License Application (BLA) for ADI-PEG 20 with U.S. FDA to Treat Malignant Pleural Mesothelioma
Aug 15, 2023
BioSpace
Polaris: Global Coalition for Adaptive Research and Polaris Group Announce Commencement of ADI-PEG 20 in GBM AGILE Trial
Jan 28, 2022
Citybizlist
Polaris: Polaris to Expand Vacaville Site with Acquisition of 15 Acres
Jan 27, 2022
Pharmaceutical Processing World
Polaris: Polaris Pharmaceuticals extends operations in Northern California
Jul 09, 2018
PharmiWeb
Polarispharma: Polaris Announces Drs. James Allison and Padmanee Sharma Joining its Scientific Advisory Board
Jun 03, 2018
PharmiWeb
Polarispharma: Polaris Group Presents Results for Phase 1 Clinical Study with its Lead Therapeutic Candidate ADI-PEG 20 Plus FOLFOX in Hepatocellular Carcinoma
Polaris Competitors
1
2
3
4
5
6
7
8
9
10